BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32451258)

  • 1. Can complementary and alternative medicines be beneficial in the treatment of COVID-19 through improving immune system function?
    Nilashi M; Samad S; Yusuf SYM; Akbari E
    J Infect Public Health; 2020 Jun; 13(6):893-896. PubMed ID: 32451258
    [No Abstract]   [Full Text] [Related]  

  • 2. Respiratory Virus Infections: Understanding COVID-19.
    Subbarao K; Mahanty S
    Immunity; 2020 Jun; 52(6):905-909. PubMed ID: 32497522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-Free Therapies: Novel Approaches for COVID-19.
    Maron-Gutierrez T; Rocco PRM
    Front Immunol; 2020; 11():583017. PubMed ID: 33072130
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
    Nowill AE; de Campos-Lima PO
    J Immunol; 2020 Nov; 205(10):2566-2575. PubMed ID: 32958687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.
    Abid MB; Mughal M; Abid MA
    JAMA Oncol; 2020 Oct; 6(10):1529-1530. PubMed ID: 32433719
    [No Abstract]   [Full Text] [Related]  

  • 6. Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms.
    Raucci F; Mansour AA; Casillo GM; Saviano A; Caso F; Scarpa R; Mascolo N; Iqbal AJ; Maione F
    Autoimmun Rev; 2020 Jul; 19(7):102572. PubMed ID: 32376393
    [No Abstract]   [Full Text] [Related]  

  • 7. Seeking and destroying the evils from the inside-translating cancer immunity to fight COVID-19.
    Dong H
    Cancer Immunol Immunother; 2020 Jun; 69(6):911-912. PubMed ID: 32347359
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of Complementary and Alternative Medicine in Prevention and Treatment of COVID-19: An Overhyped Hope.
    Shankar A; Dubey A; Saini D; Prasad CP
    Chin J Integr Med; 2020 Aug; 26(8):565-567. PubMed ID: 32761336
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of IgG antibody during the follow-up in patients with COVID-19 infection.
    Liu J; Guo J; Xu Q; Cai G; Chen D; Shen Y
    Crit Care; 2020 Jul; 24(1):448. PubMed ID: 32690058
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical course of COVID-19 in 41 patients with immune-mediated inflammatory diseases: Experience from humanitas center, Milan.
    Allocca M; Guidelli GM; Borroni RG; Selmi C; Narcisi A; Danese S; Fiorino G
    Pharmacol Res; 2020 Oct; 160():105061. PubMed ID: 32629021
    [No Abstract]   [Full Text] [Related]  

  • 11. Audio Interview: Approaches to Covid-19 Vaccines and Antivirals.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Apr; 382(16):e58. PubMed ID: 32320592
    [No Abstract]   [Full Text] [Related]  

  • 12. The allergist/immunologist, the Janus gatekeeper of inflammation, COVID-19 and beyond.
    Bellanti JA; Settipane RA
    Allergy Asthma Proc; 2020 Nov; 41(6):395-396. PubMed ID: 33109305
    [No Abstract]   [Full Text] [Related]  

  • 13. The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports").
    Persad G; Emanuel EJ
    JAMA; 2020 Jun; 323(22):2241-2242. PubMed ID: 32374357
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 and post-traumatic stress disorder: A vicious circle involving immunosuppression.
    Liang X; Zhu Y; Fang Y
    CNS Neurosci Ther; 2020 Aug; 26(8):876-878. PubMed ID: 32678521
    [No Abstract]   [Full Text] [Related]  

  • 15. Call to Action: Announcing the Traditional, Complementary and Integrative Health and Medicine COVID-19 Support Registry.
    Weeks J
    J Altern Complement Med; 2020 Apr; 26(4):256-258. PubMed ID: 32250655
    [No Abstract]   [Full Text] [Related]  

  • 16. [COVID-19- what have we learned and where are we heading?].
    Gudnason T
    Laeknabladid; 2020 Oct; 106(10):449. PubMed ID: 32991305
    [No Abstract]   [Full Text] [Related]  

  • 17. Covid-19 and Immunity in Aging Populations - A New Research Agenda.
    Koff WC; Williams MA
    N Engl J Med; 2020 Aug; 383(9):804-805. PubMed ID: 32302079
    [No Abstract]   [Full Text] [Related]  

  • 18. Covid-19: Human challenge studies will see people purposefully infected with virus.
    Mahase E
    BMJ; 2020 Oct; 371():m4101. PubMed ID: 33093016
    [No Abstract]   [Full Text] [Related]  

  • 19. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
    Cunha LL; Perazzio SF; Azzi J; Cravedi P; Riella LV
    Front Immunol; 2020; 11():1748. PubMed ID: 32849623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Privileges and Immunity Certification During the COVID-19 Pandemic.
    Hall MA; Studdert DM
    JAMA; 2020 Jun; 323(22):2243-2244. PubMed ID: 32374358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.